- Report
- October 2024
- 184 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- June 2024
- 100 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- September 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- February 2024
- 150 Pages
Global
From €4532EUR$4,750USD£3,796GBP
- Report
- February 2024
- 150 Pages
Global
From €4532EUR$4,750USD£3,796GBP
- Report
- June 2024
- 183 Pages
Global
From €4675EUR$4,900USD£3,916GBP
- Report
- March 2024
- 200 Pages
Global
From €3960EUR$4,150USD£3,317GBP
- Report
- January 2024
- 200 Pages
Global
From €3960EUR$4,150USD£3,317GBP
- Report
- July 2024
- 139 Pages
United States
From €3529EUR$3,699USD£2,956GBP
- Report
- February 2024
- 70 Pages
Europe
From €4532EUR$4,750USD£3,796GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4532EUR$4,750USD£3,796GBP
- Report
- February 2024
- 70 Pages
North America
From €4532EUR$4,750USD£3,796GBP
- Report
- February 2024
- 70 Pages
United States
From €4532EUR$4,750USD£3,796GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4532EUR$4,750USD£3,796GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4532EUR$4,750USD£3,796GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4532EUR$4,750USD£3,796GBP
- Report
- September 2024
- 110 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- May 2024
- 128 Pages
Global
From €6201EUR$6,499USD£5,194GBP
- Report
- May 2024
- 129 Pages
Global
From €6201EUR$6,499USD£5,194GBP
- Report
- May 2024
- 140 Pages
Global
From €6201EUR$6,499USD£5,194GBP
The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more